title: [A model for structured introduction of new drugs. The aim is to offer all patients appropriate treatment].
authors.affiliation: Läkemedelscentrum, Stockholms. lars-l.gustafsson@ki.se
authors.forename: Lars L
authors.initials: LL
authors.lastname: Gustafsson
authors.forename: Björn
authors.initials: B
authors.lastname: Wettermark
authors.forename: Mats
authors.initials: M
authors.lastname: Kalin
authors.forename: Seher
authors.initials: S
authors.lastname: Korkmaz
authors.forename: Marie E
authors.initials: ME
authors.lastname: Persson
authors.forename: Henrik
authors.initials: H
authors.lastname: Almkvist
authors.forename: Paul
authors.initials: P
authors.lastname: Hjemdahl
authors.forename: Margaretha
authors.initials: M
authors.lastname: Julander
authors.forename: Krister
authors.initials: K
authors.lastname: Kristianson
authors.forename: Bo
authors.initials: B
authors.lastname: Ringertz
authors.forename: Gunilla Thörnwall
authors.initials: GT
authors.lastname: Bergen-Dahl
authors.forename: Nils
authors.initials: N
authors.lastname: Wilking
mesh_terms: D035843:Biomedical Research / Q000592:standards; D003362:Cost-Benefit Analysis; D017277:Drug Approval; D016527:Drug Costs / Q000639:trends; D055808:Drug Discovery / Q000191:economics / Q000592:standards; D004341:Drug Evaluation / Q000379:methods*; D004345:Drug Industry / Q000592:standards; D015507:Drugs, Investigational / Q000191:economics / Q000627:therapeutic use; D005544:Forecasting; D006801:Humans; D007391:International Cooperation; D011358:Product Surveillance, Postmarketing; D011785:Quality Assurance, Health Care; D012449:Safety
chemical_list: D015507:Drugs, Investigational